Complier average causal effects (CACE) estimate the impact of an intervention among treatment compliers in randomized trials. Methods used to estimate CACE have been outlined for parallel-arm trials (e.g., using an instrumental variables (IV) estimator) but not for other randomized study designs. Here, we propose a method for estimating CACE in randomized stepped wedge trials, where experimental units cross over from control conditions to intervention conditions in a randomized sequence. We illustrate the approach with a cluster-randomized drinking water trial conducted in rural Mexico from 2009 to 2011. Additionally, we evaluated the plausibility of assumptions required to estimate CACE using the IV approach, which are testable in stepped wedge trials but not in parallel-arm trials. We observed small increases in the magnitude of CACE risk differences compared with intention-to-treat estimates for drinking water contamination (risk difference (RD) = −22% (95% confidence interval (CI): −33, −11) vs. RD = −19% (95% CI: −26, −12)) and diarrhea (RD = −0.8% (95% CI: −2.1, 0.4) vs. RD = −0.1% (95% CI: −1.1, 0.9)). Assumptions required for IV analysis were probably violated. Stepped wedge trials allow investigators to estimate CACE with an approach that avoids the stronger assumptions required for CACE estimation in parallel-arm trials. Inclusion of CACE estimates in stepped wedge trials with imperfect compliance could enhance reporting and interpretation of the results of such trials. complier average causal effects; drinking water; household water treatment and safe storage; instrumental variables; intention-to-treat analysis; randomized stepped wedge trials Abbreviations: CACE, complier average causal effect; CI, confidence interval; HWTS, household water treatment and safe storage; ITT, intention to treat; IV, instrumental variable; RD, risk difference.
In randomized trials with imperfect compliance, the intention-to-treat (ITT) parameter will underestimate the efficacy of an intervention because some individuals, in either trial arm, may not adhere to their assigned treatment (1) (2) (3) . The complier average causal effect (CACE) parameter measures the impact of an intervention in the subgroup of the population that complies with its assigned treatment (the complier subgroup). CACE has been proposed as a complementary parameter of interest that more closely estimates treatment efficacy in trials with imperfect compliance (1, 2) . The use of instrumental variable (IV) estimators of the CACE parameter in parallel-arm trials has been well described (1, (4) (5) (6) . However, the IV estimator requires specific assumptions (e.g., the intervention only affects outcomes through compliance with treatment) that cannot be tested directly in parallel-arm trials, since the complier (and noncomplier) subgroups cannot be identified from observable data (1, 4, 5) . To our knowledge, methods and assumptions with which to estimate the CACE parameter in randomized crossover study designs have not been described.
One such crossover design is the stepped wedge trial, where investigators randomize the order in which an intervention is delivered to experimental units (e.g., individuals, communities); units cross over from control to intervention in a randomized order throughout the follow-up period, and outcomes are measured at each time point (or step) at which the units cross over (7) (8) (9) . The stepped wedge design is particularly applicable to field trials for which imperfect compliance may be of greater concern than it is in efficacy trials, such as the rollout of public health programs.
In this article, we describe methods for estimating CACE in studies with stepped wedge designs that make fewer assumptions than are required for estimation in parallelarm trials. We illustrate the method in the context of a community-randomized stepped wedge trial of a household water treatment and safe storage (HWTS) intervention delivered in rural Mexico (10) . We compare CACE estimates with ITT estimates originally reported for the trial, under the expectation that the effect of the intervention would be larger among complier households (10) . In addition, we evaluate the identification assumptions required to estimate CACE using an IV estimator, which is typically used in parallel-arm trials; these assumptions are not testable in parallel-arm trials but are testable in trials with crossover designs. We believe that the methods and results from this study will be relevant to estimation of CACE parameters in effectiveness trials using both parallel-arm and crossover designs.
METHODS CACE estimation: overview and assumptions
The CACE parameter estimates the effect of an intervention in the subgroup of the study population that complies with their assigned treatment. Methods for estimating CACE have been framed under the potential outcomes model for causal inference (1, 4, 5) . Under this model, there are 4 compliance subgroups in a study population: "compliers," "always-takers," "never-takers," and "defiers" ( Table 1 ). The 4 compliance subgroups are defined on the basis of how participants would comply with an assigned treatment under alternate (counterfactual) randomized assignments (e.g., intervention, control): Compliers will use the treatment if they are assigned to the intervention arm of the study but will not use it if they are assigned to the control arm; always-takers will use the treatment irrespective of their intervention assignment; never-takers will never use the treatment even if it is provided to them in the intervention arm; and defiers will do the opposite of their assigned treatment ( Table 1 ). Note that in this article, "intervention" refers to randomized assignment (e.g., intervention arm) and "treatment" refers to the specific mediator by which the intervention is effective (e.g., taking the assigned drug, disinfecting water).
If investigators could observe participants under both counterfactual assignments in a parallel-arm trial (intervention, control), they could then identify compliers (Table 1) and estimate CACE by comparing outcomes between intervention arms in this subgroup. However, the complier subgroup is not directly identifiable in a parallel-arm trial (Table 2) , thereby requiring (untestable) assumptions in order to estimate CACE. Specifically, it is necessary to assume that the randomized intervention monotonically affects the outcome of interest only through compliance with treatment (11) . Under the causal model for compliance, these assumptions can be encoded as exclusion restrictions: 1) defiers do not exist and 2) randomized assignment has no effect among always-takers or never-takers (see the Web Appendix, available at http://aje.oxfordjournals.org/) (1, 4) . While these assumptions might be reasonable under some conditions, their appropriateness depends on the definition of compliance, which determines subgroup composition and the potential for alternate causal pathways by which the intervention can affect outcomes (Figure 1 ). In addition, these assumptions may be of particular concern in cluster-randomized trials that involve participant behavior or infectious diseases: If one individual's compliance could influence outcomes for another individual in the same cluster, these assumptions could be violated (12) (13) (14) . Since these assumptions are generally untestable in parallel-arm trials, it is difficult to determine how biased CACE estimates would be if they were violated in those applications.
CACE estimation: stepped wedge trials
In a stepped wedge design, all experimental units start in the control arm and then "cross over" to the intervention arm in a randomized order (7) (8) (9) . Experimental units, therefore, contribute person-time to both the intervention arm and the control arm over the course of the trial, which allows observation of participant treatment usage (compliance) under both intervention and control conditions. Investigators can then categorize participants into compliance subgroups b Always-takers will use the treatment regardless of randomized assignment.
c Never-takers will never use the treatment, regardless of randomized assignment.
d Defiers do the opposite of what they were assigned to do in their treatment arm. a In a parallel-arm trial, comparing intervention arm "users" with control arm "nonusers" will yield a biased estimate of the CACE parameter because of the unobservable presence of always-takers and never-takers, respectively.
(compliers, always-takers, never-takers, and defiers) based on observable behavior. The ability to disaggregate compliers from other treatment "users" in the intervention arm and from other "nonusers" in the control arm (Table 2 ) allows investigators to estimate the CACE parameter through subgroup analyses, without the exclusion restrictions required for IV estimation (Web Appendix).
Example: Baja California Sur stepped wedge trial
Between August 2009 and January 2011, we conducted a cluster-randomized stepped wedge trial to measure the effect of a safe water program on drinking water contamination and participant diarrhea in rural Mexico. The primary ITT analysis found large improvements in water quality but only small improvements in diarrhea prevalence over 15 months of follow-up (10) .
Details on the study design, population, and outcome measurement have been published elsewhere (10) . Briefly, the trial was conducted among 24 rural communities in the Mexican state of Baja California Sur that rely on wells and springs to collect household water. Purified water (sold in reusable 20-L bottles) is available to families that regularly visit urban areas and can afford to buy it.
Fundacion Cantaro Azul, a nonprofit organization based in Mexico, distributed an ultraviolet water disinfection system (Mesita Azul; Fundacion Cantaro Azul, La Paz, Mexico) to households as part of a community-level program to promote HWTS practices (10, 15) . The primary outcomes of the trial were household drinking water contamination (the most probable number of Escherichia coli organisms per 100 mL) and participant-reported diarrhea (3 or more loose or watery stools in a 24-hour period, or 1 stool with mucus or blood; 7-day period prevalence) (10) . A stepped wedge schematic diagram for this study was previously published (10) .
CACE estimation in the Baja California Sur trial
Below, we lay out the steps we followed to identify and estimate CACE in the Baja California Sur stepped wedge trial. Specifically, we: 1) describe our treatment of interest for CACE estimation; 2) determine the causal structure implied by our treatment of interest; 3) select a working definition of compliance (based on measurable behavior) to categorize households into compliance subgroups; 4) describe our methods for evaluating the equivalence of comparison groups (balance of baseline characteristics among compliers); and 5) outline our parameters of interest and statistical methods.
Treatment of interest. In this study, we sought to identify the effect of compliance with water disinfection and safe storage habits promoted through the community intervention. Specifically, we wanted to identify intervention effects among households that exclusively drank water that was stored in a narrow-mouthed ("safe") container after commercial purification or household disinfection (Mesita Azul treatment, chlorination, or boiling). Our treatment of interest was not the Mesita Azul disinfection system itself. While evaluation of the efficacy of the Mesita Azul system (separate from other strategies) is of scientific interest, using it to define compliance has implications for the causal model used to estimate CACE, and this is discussed below.
Causal model of compliance. Freedman (5) described 2 specific causal models for compliance that are determined by the treatment of interest in a randomized trial. Specifically, whether or not treatment is available to the control group determines the presence of always-takers and defiers in the study population. If the control group has access to treatment, then all 4 compliance subgroups exist. If, however, treatment is effectively controlled by investigators and is not available to control households, then always-takers and defiers cannot exist (Table 1) . Under both models, it is necessary to make exclusion restrictions to estimate CACE in a parallel-arm trial; in a stepped wedge trial, the choice of model determines which subgroups are present. In the Baja California Sur trial, water treatment (chlorination, boiling, purification) and safe storage strategies were widely available to households while they were assigned to the control arm, implying the presence of all 4 compliance subgroups.
Classification of subgroups. Once the treatment of interest has been determined, it is necessary to establish working definitions of compliance based on observed behavior and to categorize participants into compliance subgroups, guided by subject matter knowledge. Investigators should confirm that there are sufficient numbers of compliers in the study population; the trial will have limited power to estimate CACE with low compliance. Additionally, while treatment-usage patterns can vary, the parameter of interest described in this article assumes that subgroup membership is stable throughout the study period; definitions of compliance should be consistent with this assumption. In our example, we constructed subgroup classifications based on cumulative behaviors to account for time-varying treatment-usage patterns. Specifically, we classified households as compliers if they did not practice safe water habits during any visit while in the control arm but were observed to treat and store all of 1136 Gruber et al.
their water in narrow-mouthed containers during at least 1 visit after receiving the intervention. Always-taker households were observed to treat and safely store all water during at least 1 control visit and at least 1 intervention visit. Nevertaker households were not observed to be treating and safely storing all of their water at any visit. Defier households were observed to treat and safely store all of their water during at least 1 control visit but not during any intervention visits ( Table 1) . The implicit assumption is that subgroup membership is a preexisting characteristic and that treatment usage at a given step is independent of prior outcomes.
Equivalence of comparison groups. For CACE subgroup analyses, randomization should balance participant characteristics across control and intervention periods, but it does not guarantee exchangeability. To check for balance in observable characteristics among compliers, we calculated a weighted average of baseline characteristics by the amount of time a household spent in either control or intervention time periods (10) . For example, if a household crossed over in step 3, it contributed baseline characteristics to 3 control time periods (steps 0-2) and 4 intervention time periods (steps 3-6). Balance for ITT analyses was previously reported (10) .
Parameters of interest and statistical estimation. Here we provide an overview of CACE estimation in a stepped wedge trial; the Web Appendix includes a comprehensive overview of parameter estimation and required assumptions for both designs.
The parameter of interest for a randomized stepped wedge trial in which time affects the outcome of interest is the difference in expectation between randomized groups, conditional on time step:
where Y i is a binary or continuous outcome, A is an indicator of randomized intervention (A = 1) or control (A = 0) status, and T indexes time step.
Step-specific estimates avoid conflating the effect of time with the effect of the intervention from a direct comparison of mean values across all steps (Web Appendix) (7) . Under the assumptions that 1) intervention history prior to step t does not affect outcomes (Y) at step t and 2) intervention effects across steps are constant (E[Y|A = 1,
is not a function of t), step-specific estimates can be averaged to estimate a summary effect of the intervention across all steps:
where n is the total number of participants and s is the total number of steps.
The step-specific CACE parameter is characterized as
where C is an indicator of being a complier (C = 1). Using the same assumptions as above, and assuming that C is a preexisting characteristic that is stable throughout the study period, step-specific CACE estimates can be averaged over all steps to produce a summary estimate:
Our primary parameter of interest is the risk difference, described in equations 1-4 using a binary outcome. However, for consistency with previously published HWTS trials, we also estimate prevalence ratios (relative risks), which are described by replacing the differences in equations 1-4 with quotients.
For all parameters, we estimated effects for 1) the percentage of households with contaminated drinking water and 2) the 7-day period prevalence of diarrhea. We estimated these parameters by modeling outcomes as
where Y = 1 if a participant, at time t, had ≥1 most probable number of E. coli organisms per 100 mL of drinking water (household) or an episode of diarrhea in the previous 7 days (individual) (otherwise Y = 0); A = 1 if a community was assigned to the intervention arm at time t (A = 0 otherwise); I(T = t) is an indicator of step ðt ∈ f0; 1; 2; 3; 4; 5; 6gÞ; and γ t is the fixed effect of step(t) on contaminated drinking water or diarrhea. Including a fixed effect for step in equation 5 is analogous to stratifying by step (7). We modeled outcomes using linear and modified Poisson regression (β was interpreted as a risk difference in linear models and as a relative risk in Poisson models) (16) . To account for clustering at the community level, we estimated confidence intervals using robust standard errors. We estimated CACE parameters by restricting analyses to complier households and reestimated effects using the same methods.
Ethical considerations
Considerations regarding informed consent and approval of trial procedures were previously published (10) .
RESULTS

Study population
We enrolled 444 households (1,731 individuals) into the original trial cohort. As reported previously, randomization balanced measurable characteristics between control periods and intervention periods among the entire (ITT) study population (10) . Of 444 enrolled households, we classified 173 households (730 individuals) as compliers, 84 households (290 individuals) as always-takers, 122 households (473 individuals) as never-takers, and 9 households (28 individuals) as defiers (Web Tables 1 and 2 ). We could not categorize 56 households (210 individuals) because of missing data during either control periods or intervention periods; these households were excluded from analyses. Web Table 3 shows treatment usage patterns by subgroup and intervention arm.
Compared with the other subgroups, always-takers had improved baseline measures of education, household water quality, hygiene and sanitation, socioeconomic factors, and household infrastructure (Web Tables 1 and 2 ). Compliers and never-takers appeared to differ in terms of several baseline characteristics, but we observed no consistent pattern of improved measures in either group. The low number of defier households (n = 9) made it difficult to interpret results in this subgroup. After restricting the analysis to compliers, we observed that, on average, randomization balanced measured baseline characteristics between control and intervention time periods at both the individual (Tables 3 and 4 ) and household (Table 5 ) levels. Table 6 includes marginal population frequencies for all subjects and for compliers. Accounting for time effects, we observed significant reductions in drinking water contamination among compliers (CACE risk difference (RD) = −22%, 95% confidence interval (CI): −33, −11), which were larger in magnitude than reductions in the total population (ITT RD = −19%, 95% CI: −26, −12) (10). We observed a similar relationship for relative risks (Table 6 ).
Water contamination
Diarrhea
Diarrhea was relatively rare during our study (3.1% during control periods), leading to small, imprecise effect estimates (10) . However, we observed larger effects among compliers (CACE RD = −0.8% (95% CI: −2.1, 0.4); relative risk = 0.62 (95% CI: 0.33, 1.16)) in comparison with ITT estimates (RD = −0.1% (95% CI: −1.1, 0.9); relative risk = 0.80 (95% CI: 0.51, 1.27)) ( Table 6 ).
Intervention effects among noncompliers
We evaluated disinfection practices among households that did not meet our full definition of compliance (e.g., never-takers who had treated water present during a visit but either did not store it in a narrow-mouthed container or simultaneously had untreated drinking water available). The intervention increased overall use of disinfection practices (any method) among never-takers (RD = 24%, 95% CI: 12, 36), mediated primarily by use of the Mesita Azul disinfection system (Table 7) . We also observed an increase in disinfection practices (any method) among always-takers, probably mediated by a substitution effect wherein use of purified water dropped significantly (RD = −43%, 95% CI: −59, −27) while use of the Mesita Azul system significantly increased (RD = 53%, 95% CI: 39, 66) ( Table 7) . We observed significant reductions in E. coli contamination among never-takers (RD = −14%, 95% CI: −27, −1) and always-takers (RD = −16%, 95% CI: −27, −4) ( Table 8) . We did not observe any differences in diarrhea for these subgroups.
DISCUSSION
Summary of main results
In this paper, we illustrated a novel approach for estimating the effect of an intervention among persons who complied with their randomized treatment assignment in a stepped wedge trial. We used a community-level HWTS intervention in rural Mexico to demonstrate the approach. We classified 173 households as compliers (40%) and used this group to estimate the CACE parameter directly through subgroup analyses. Consistent with our expectations, we found that the CACE estimates were larger in magnitude than ITT estimates for both water quality and diarrhea (Table 6 ). We took advantage of the stepped wedge design to further evaluate whether the assumptions necessary to estimate CACE in parallel-arm trials held in our study; we were able to evaluate these assumptions empirically because we could observe and directly estimate intervention effects among the noncomplier subgroups (which could not be estimated in a parallel-arm design). We found that these assumptions probably did not hold (Tables 5 and 6 ). Overall, our results suggest that the CACE parameter is a valuable complement of ITT estimates in stepped wedge trials with imperfect compliance and that it can be estimated using a simple subgroup analysis when suitable measures of compliance are available.
Interpretation
In trials with imperfect compliance where a measure of treatment efficacy is desired, CACE estimates are a preferred alternative to "per-protocol" and "as-treated" analyses, because the latter 2 types of analyses are highly vulnerable to bias from unobservable characteristics (4, 5). As we demonstrated in this study, stepped wedge designs (and crossover designs more generally) enable investigators to observe treatment usage under both intervention and control conditions and allow investigators to estimate CACE with a straightforward subgroup analysis. The methods we demonstrate in this paper further allow investigators to evaluate balance in observable characteristics among compliers across intervention arms with an intuitive and parsimonious approach (Tables 3-5) (10) . What distinguishes the methods demonstrated in this article is their ability to estimate CACE parameters in crossover designs without the identification assumptions required for IV analysis and CACE estimation in parallel-arm trials. Abbreviations: CI, confidence interval; RD, risk difference. a Households that did not meet the definition of compliance because treated water was stored in a wide-mouthed (unsafe) container or alternate sources of untreated water were available.
b All models were stratified by step (see Methods section of text). c Mesita Azul water disinfection system (Fundacion Cantaro Azul, La Paz, Mexico). Two study households acquired a Mesita Azul system from family members in a pilot area prior to the start of baseline data collection. We do not report IV results in the main body of this article, out of concern that the necessary identification assumptions were violated. First, the IV approach assumes that the only path between randomized assignment and outcomes is through the treatment of interest (in this study, water treatment and safe storage (Figure 1) ) (1, 4, 6, 11) . From a theoretical perspective, we were concerned about alternate intervention pathways in our study because we randomized at the community level but measured compliance at the household level; thus, the water treatment habits of one household in a community could have affected the outcomes of other households in that community-either through modeled behavior or through enteric pathogen transmission (12) . Empirically, we also observed significant water quality improvements among never-takers and always-takers (Table 8) , indicating a clear violation of the assumption that randomized assignment does not affect potential outcomes in these groups (1) . Second, we identified a small number of defiers (n = 9), which violates an exclusion restriction (absence of defiers) and could affect IV estimates. We provide IV estimates in the Web Appendix for comparison purposes, and we note that they differ substantially from those of our CACE subgroup analysis (Web Appendix and Table 6 ); we expect differences between the estimators to stem from violations of the assumptions discussed above. Taken together, our results suggest that in parallel-arm trials that report CACE estimates using an IV approach, investigators need to carefully evaluate the plausibility of the required identification assumptions.
In many study contexts there is no standard definition of compliance, and any definition must be determined using subject matter knowledge and the practicalities of observable data. As we demonstrated in this study, the chosen definition of compliance will have an impact on the causal model of compliance, the assumptions required for CACE analyses, and ultimate effect estimates. In this study we used a compliance definition that combined drinking water treatment with safe storage because that was the message promoted by the community intervention. An alternative question of interest (e.g., for engineers) could have been the effect of using the Mesita Azul water disinfection system (the technology distributed in this trial). This alternate definition would have affected the presence of subgroups (defiers, always-takers) and subgroup composition (household categorization), and therefore the potential for alternate pathways by which the intervention could affect study outcomes (Figure 1 ). While CACE estimates based on subgroup analyses in stepped wedge trials are less likely than IV estimates to be biased by violations of model assumptions, compliance definitions should be considered carefully, as they will still influence effect estimates and the interpretation of results.
Consistent with primary analyses in randomized trials, CACE analyses in studies with stepped wedge designs should be prespecified (17) , taking into consideration the steps outlined in this article: Choose the treatment of interest, determine the causal structure implied by the treatment of interest, develop a measurable working definition of compliance, and determine whether there will be a sufficient number of compliers to estimate effects with precision. When possible, investigators should also prespecify methods for determining covariate balance and statistical methods for estimating CACE.
Given the infectious nature of diarrheal pathogens, CACE estimates from HWTS intervention trials will be contextspecific. In settings where there are high levels of pathogen transmission from environmental hygiene and sanitation pathways, investigators should expect smaller ITT effects from drinking water interventions because the estimated intervention effects are conditional on transmission loads from other environmental pathways (18, 19) . For the same reasons, ITT and CACE estimates in HWTS trials will also be conditional on levels of community compliance. For example, if compliance with an HWTS intervention is low and within-community pathogen transmission rates are high, investigators should expect HWTS interventions to lead to smaller reductions in diarrhea. Both ITT and CACE estimates should be larger with higher levels of overall compliance (20) (21) (22) (23) .
Limitations
The CACE analyses presented in this study were not prespecified. Estimating CACE in any study requires careful consideration of the working definition of compliance and classification of subgroups. While membership in our subgroups was stable throughout the study period (by assumption; see Methods section) and met the assumptions necessary to estimate CACE in our trial, we probably did not capture "true" compliance (100% usage of safe water habits; Web Table 3 ). Our subgroup classifications allowed us to identify a meaningful CACE parameter and demonstrate the methods presented in this article; however, exploring classifications of subgroups based on time-varying compliance history to further delineate participant subgroup membership could represent an avenue for future research. In our stepped wedge trial, households had different probabilities of being classified into one of the subgroups, depending on how much observation time was contributed to intervention or control time periods. With a sufficiently large sample, randomization will reduce any bias from differential observation times across intervention arms, but in future research investigators could explore methods for handling this issue in (smaller) finite samples. In our trial, we were unable to classify 56 households (13%) into a compliance subgroup; CACE estimates could be biased if the missing group included compliers that differed from compliers in the analytic sample. We conducted a sensitivity analysis in which we included all 56 missing households in the complier subgroup and reestimated the CACE parameter (to bound potential biases due to the exclusion of these households); inclusion of the missing households in the analysis did not greatly influence our effect estimates (Web Table 4 ).
Conclusion
In this study, we outlined a novel approach to estimating CACE in randomized studies with stepped wedge designs and demonstrated this approach in an HWTS field trial designed to reduce drinking water contamination and diarrhea in rural Mexico. Compliers experienced larger reductions in drinking water contamination and reported diarrhea. We found evidence of intervention effects among noncompliers, a clear violation of the assumptions required for unbiased CACE estimation using an IV estimator. This finding underscores the reality that even though CACE analyses can be useful complements to ITT analysis in trials with imperfect compliance, investigators should consider carefully the definition of treatment compliance and should prespecify CACE analyses.
